Mucinex Dm
NDC Package 17856-0056-1

11-digit billing NDC: 17856005601
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mucinex Dm is do not crush, chew, or break tablettake with a full glass of waterthis product can be administered without regard for timing of mealsadults and children 12 years and older: 1 or 2 tablets every 12 hours; not more than 4 tablets in 24 hourschildren under 12 years of age: do not use. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-0056 and is authorized under FDA application NDA021620.

Identification & Billing

NDC Package Code
17856-0056-1
Package Description
1 TABLET, EXTENDED RELEASE in 1 PACKAGE
Product Code
17856-0056
11-Digit Billing Format
17856005601
RxNorm Crosswalk
  • RxCUI: 1298324 - guaiFENesin 600 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet
  • RxCUI: 1298324 - 12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG Extended Release Oral Tablet
  • RxCUI: 1298324 - dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG 12 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Mucinex Dm
Dosage Form
-
Usage Information
Do not crush, chew, or break tablettake with a full glass of waterthis product can be administered without regard for timing of mealsadults and children 12 years and older: 1 or 2 tablets every 12 hours; not more than 4 tablets in 24 hourschildren under 12 years of age: do not use

Regulatory & Marketing

Labeler Name
Atlantic Biologicals Corp.
FDA Application #
NDA021620
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-26-2012
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17856-0056-1 identifies a specific commercial package of 1 tablet, extended release in 1 package of Mucinex Dm, labeled by Atlantic Biologicals Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corp. on June 26, 2012. The current certification is valid through December 31, 2025.

How is this Atlantic Biologicals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856005601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
17856-0056-1
11-Digit CMS (5-4-2)
17856-0056-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.